EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Proximity Elongation Assay and ELISA for the Identification of Serum Diagnostic Biomarkers in Parkinson’s Disease and Progressive Supranuclear Palsy

Costanza Maria Cristiani iD, Camilla Calomino iD, Luana Scaramuzzino iD, Maria Stella Murfuni, Elvira Immacolata Parrotta iD, Maria Giovanna Bianco iD, Giovanni Cuda iD, Aldo Quattrone, Andrea Quattrone

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111663 ↗

At a glance

Journal article in International Journal of Molecular Sciences, 2024. Written by Costanza Maria Cristiani and 8 co-authors. Institution: Neuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy. Major MEDLINE topics: Parkinson Disease, Supranuclear Palsy, Progressive, Biomarkers, Enzyme-Linked Immunosorbent Assay. Cited 5 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY 4.0). Funded by: Italian Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Clinical differentiation of progressive supranuclear palsy (PSP) from Parkinson’s disease (PD) is challenging due to overlapping phenotypes and late onset of PSP specific symptoms, highlighting the need for easily assessable biomarkers. We used proximity elongation assay (PEA) to analyze 460 proteins in serum samples from 46 PD, 30 PSP patients, and 24 healthy controls. ANCOVA was used to identify the most promising proteins and machine learning (ML) XGBoost and random forest algorithms to assess their classification performance. Promising proteins were also quantified by ELISA. Moreover, correlations between serum biomarkers and biological and clinical features were investigated. We identified five proteins (TFF3, CPB1, OPG, CNTN1, TIMP4) showing different levels between PSP and PD, which achieved good performance (AUC: 0.892) when combined by ML. On the other hand, when the three most significant biomarkers (TFF3, CPB1 and OPG) were analyzed by ELISA, there was no difference between groups. Serum levels of TFF3 positively correlated with age in all subjects’ groups, while for OPG and CPB1 such a correlation occurred in PSP patients only. Moreover, CPB1 positively correlated with disease severity in PD, while no correlations were observed in the PSP group. Overall, we identified CPB1 correlating with PD severity, which may support clinical staging of PD. In addition, our results showing discrepancy between PEA and ELISA technology suggest that caution should be used when translating proteomic findings into clinical practice.

Subjects

MeSH terms (MEDLINE)

Parkinson DiseaseSupranuclear Palsy, ProgressiveBiomarkersEnzyme-Linked Immunosorbent AssayHumansMaleFemaleAgedMiddle AgedMachine LearningTrefoil Factor-3OsteoprotegerinCase-Control StudiesDiagnosis, Differential

Author keywords

PEAParkinson’s diseasemachine learningprogressive supranuclear palsy

Substances

BiomarkersTrefoil Factor-3OsteoprotegerinTFF3 protein, human

Authors and institutions

  • Neuroscience Research Center, University "Magna Graecia", 88100 Catanzaro, Italy.
  • Research Centre for Advanced Biochemistry and Molecular Biology, Department of Clinical and Experimental Medicine, University "Magna Graecia", 88100 Catanzaro, Italy.
  • Institute of Molecular Biology, Department of Medical and Surgical Sciences, University "Magna Graecia", 88100 Catanzaro, Italy.
  • Institute of Neurology, Department of Medical and Surgical Sciences, University "Magna Graecia", 88100 Catanzaro, Italy.

ORCID profiles: Costanza Maria Cristiani, Camilla Calomino, Luana Scaramuzzino, Elvira Immacolata Parrotta, Maria Giovanna Bianco, Giovanni Cuda

Funding

  • Italian Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP)

Cite

APA

Cristiani, C. M., Calomino, C., Scaramuzzino, L., Murfuni, M. S., Parrotta, E. I., Bianco, M. G., Cuda, G., Quattrone, A., & Quattrone, A. (2024). Proximity Elongation Assay and ELISA for the Identification of Serum Diagnostic Biomarkers in Parkinson’s Disease and Progressive Supranuclear Palsy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111663

Vancouver

Cristiani CM, Calomino C, Scaramuzzino L, Murfuni MS, Parrotta EI, Bianco MG, et al. Proximity Elongation Assay and ELISA for the Identification of Serum Diagnostic Biomarkers in Parkinson’s Disease and Progressive Supranuclear Palsy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111663

BibTeX
@article{Cristiani2024,
  author = {Cristiani, Costanza Maria and Calomino, Camilla and Scaramuzzino, Luana and Murfuni, Maria Stella and Parrotta, Elvira Immacolata and Bianco, Maria Giovanna and Cuda, Giovanni and Quattrone, Aldo and Quattrone, Andrea},
  title = {Proximity Elongation Assay and ELISA for the Identification of Serum Diagnostic Biomarkers in Parkinson’s Disease and Progressive Supranuclear Palsy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111663}
}
Start for free →